Data from a federal program designed to compensate people harmed by vaccines shows how rare it is for someone to claim they were hurt after getting vaccinated

Quick Read

No one expected the four young women to live much longer. They had an extremely rare, aggressive and fatal form of ovarian cancer. There was no standard treatment

Quick Read

In April, Gundy’s child, who is on private insurance, began getting the drug Spinraza, which costs $750,000 for the initial year of treatment. Chaffin’s child — a Medicaid enrollee — was not receiving the drug, as his state regulators debated whether to offer it to children like him who use ventilators to breathe

Quick Read

With a flagship treatment that helps fewer than 11,000 people, how is Alexion making so much money?

Quick Read